These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 7920309)

  • 1. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines involved in graft-versus-host disease.
    Imamura M; Tanaka J; Hashino S; Kobayashi H; Hirano S; Minagawa T; Imai K; Kobayashi S; Fujii Y; Kasai M
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1348-53. PubMed ID: 7705747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels.
    Imamura M; Hashino S; Kobayashi S; Kobayashi H; Tanaka J; Imai K; Kasai M; Sakurada K; Miyazaki T
    Int J Hematol; 1994 Jul; 60(1):85-9. PubMed ID: 7919241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine expression in human cutaneous chronic graft-versus-host disease.
    Ochs LA; Blazar BR; Roy J; Rest EB; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1085-92. PubMed ID: 8807119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
    Yabe M; Yabe H; Hattori K; Shimizu T; Matsumoto M; Morimoto T; Yasuda Y; Inoue H; Kato S; Nishimura T
    Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
    Remberger M; Ringden O; Markling L
    Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Ritchie D; Seconi J; Wood C; Walton J; Watt V
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):706-12. PubMed ID: 16125641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM; Bensen-Kennedy D; Miura Y; Thoburn CJ; Armstrong D; Vogelsang GB; Hess AD
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Mauz-Körholz C; Körholz D; Burdach S
    J Lab Clin Med; 1995 Aug; 126(2):144-50. PubMed ID: 7636387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Rowbottom AW; Riches PG; Downie C; Hobbs JR
    Bone Marrow Transplant; 1993 Dec; 12(6):635-41. PubMed ID: 8136747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A; Barak V; Novick D; Nagler A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The experimental results of GVHD following orthotropic liver transplantation].
    Yao GL; Li W; Liu AB; Liang H; Song LJ; Wang ME; Liu YM; Wang L; Wang HY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):856-60. PubMed ID: 19958648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.